Full View

Biomarker testing for patients with advanced non–small cell lung cancer: real-world issues and tough choices

NA Pennell, ME Arcila, DR Gandara… - American Society of …, 2019 - ascopubs.org
Over the last decade, the treatment of patients with advanced non–small cell lung cancer
(NSCLC) has become reliant on tissue and/or blood biomarkers to help guide treatment …
被引用次数：295 相关文章

Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.

NA Pennell, ME Arcila, DR Gandara… - American Society of …, 2019 - europepmc.org
Over the last decade, the treatment of patients with advanced non-small cell lung cancer
(NSCLC) has become reliant on tissue and/or blood biomarkers to help guide treatment …

Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices

NA Pennell, ME Arcila… - American Society of …, 2019 - pubmed.ncbi.nlm.nih.gov
Over the last decade, the treatment of patients with advanced non-small cell lung cancer
(NSCLC) has become reliant on tissue and/or blood biomarkers to help guide treatment …

Biomarker Testing for Patients With Advanced Non–Small Cell Lung Cancer: Real-World Issues and Tough Choices

NA Pennell, ME Arcila, DR Gandara… - American Society of …, 2019 - cir.nii.ac.jp
抄録< jats: p> Over the last decade, the treatment of patients with advanced non–small cell
lung cancer (NSCLC) has become reliant on tissue and/or blood biomarkers to help guide …